Literature DB >> 15195073

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a.

P Kaloyannidis, I Sakellari, A Fassas, T Fragia, S Vakalopoulou, C Kartsios, B Garypidou, V Kimiskidis, A Anagnostopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195073     DOI: 10.1038/sj.bmt.1704550

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis.

Authors:  Jarrett Madeley; Georgina Hodges; Andrew Birchley
Journal:  BMJ Case Rep       Date:  2018-10-17

2.  A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.

Authors:  R Saccardi; M S Freedman; M P Sormani; H Atkins; D Farge; L M Griffith; G Kraft; G L Mancardi; R Nash; M Pasquini; R Martin; P A Muraro
Journal:  Mult Scler       Date:  2012-03-01       Impact factor: 6.312

Review 3.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

Review 4.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

Review 5.  Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Nataliya Prokopenko Buxbaum; Steven Z Pavletic
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.